医疗器械行业

Search documents
长城医疗保健混合A,长城医疗保健混合C: 长城医疗保健混合型证券投资基金2025年第2季度报告
Zheng Quan Zhi Xing· 2025-07-12 02:26
长城医疗保健混合型证券投资基金 基金管理人:长城基金管理有限公司 基金托管人:中国建设银行股份有限公司 报告送出日期:2025 年 7 月 12 日 长城医疗保健混合 2025 年第 2 季度报告 §1 重要提示 本基金管理人的董事会及董事保证本报告所载资料不存在虚假记载、误导性陈述或重大遗漏, 并对其内容的真实性、准确性和完整性承担个别及连带责任。 本基金托管人中国建设银行股份有限公司根据本基金合同规定,于 2025 年 07 月 11 日复核了 本报告中的财务指标、净值表现和投资组合报告等内容,保证复核内容不存在虚假记载、误导性 陈述或者重大遗漏。 本基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产,但不保证基金一定盈 利。 基金的过往业绩并不代表其未来表现。投资有风险,投资者在作出投资决策前应仔细阅读本 基金的招募说明书。 投资目标 本基金重点投资于医疗保健行业上市公司,在控制风险 的前提下,采用积极主动的投资策略,力求实现超越业 绩比较基准的表现。 投资策略 本基金为混合型证券投资基金,将依据市场情况调整大 类资产配置比例。本基金采用"自上而下"和"自下而 上"相结合的方法进行大类资产配置。 ...
上市公司破产重整中的62个疑难问题(附81案例)
梧桐树下V· 2025-06-25 11:15
Core Viewpoint - The article discusses the recent regulatory changes by the China Securities Regulatory Commission regarding bankruptcy reorganization, emphasizing the increased complexity and requirements for companies seeking to revive through this process. Group 1: Key Practical Points of Bankruptcy Reorganization - If a bankrupt entity has lost financial independence due to the unified management of funds, it can undergo consolidated reorganization, followed by a hearing to gather opinions before a ruling [1] - Reorganization and restructuring can proceed simultaneously; if there are many small creditors with low repayment rates, a small creditor group can be established to improve their repayment ratio [1] - The liquidation team should hire intermediaries and experts to ensure asset preservation and value increase, introducing suitable strategic investors to implement the reorganization plan [1] - In cases of multiple related companies in bankruptcy, a competitive method can be used to appoint a joint administrator; for large entities with complete capacity and technical support, industry transformation and investment attraction can be employed [1][2] Group 2: Conditions and Strategies for Reorganization - The conditions for consolidated reorganization include a high degree of confusion among related enterprises' personalities and assets, making it difficult to distinguish between them without harming creditor interests [2] - For projects unsuitable for consolidated reorganization, a "bottom-up" reorganization order can be established, allowing subsidiaries to complete reorganization first, ensuring that lower-tier companies can repay internal loans to upper-tier companies [2] Group 3: Improving Reorganization Success Rates - The pre-reorganization model can enhance the success rate and efficiency of reorganization by incorporating assets and increasing shares to repay debts, thereby improving debt repayment rates and acceptance of the reorganization plan [3] Group 4: Challenges Faced by Companies - The average proportion of current liabilities for private listed companies reached 67% in 2023, significantly higher than the 48% for state-owned enterprises, indicating a reliance on short-term debt financing [7] - Among private enterprises entering reorganization from 2022 to 2024, 62% faced "short-term loans for long-term investments" issues, and 38% involved major shareholder fund occupation, with a secondary reorganization rate of 29% [8] Group 5: State-Owned Enterprises and Reorganization - The proportion of state-owned enterprise reorganization cases increased from 9% in 2022 to 15% in 2024, reflecting significant structural changes in ownership [9] - Supply-side reforms have led to successful transformations, such as a provincial steel group replacing outdated capacity with special steel production lines, improving profit margins [9]
金十图示:2025年05月28日(周三)富时中国A50指数成分股今日收盘行情一览:石油、煤炭板块全天飘红,银行、汽车板块午后继续涨跌互现
news flash· 2025-05-28 07:12
金十图示:2025年05月28日(周三)富时中国A50指数成分股今日收盘行情一览:石油、煤炭板块全天飘红,银行、汽车板块午 后继续涨跌互现 @ JIN10.COM 金十数据 | 一个交易工具 JIN10.COM 电力行业 互联网服务 长江电力 88 中国核电 1982.76亿市值 东方财富 a 2018-02-1 7470.15亿市值 3239.83亿市值 16.37亿成交额 5.55亿成交额 27.20亿成交额 30.53 9.64 20.50 +0.27(+0.89%) -0.01(-0.10%) -0.19(-0.92%) 食品饮料 证券 中信证券 国泰海通 海天味业 (D 3037.60亿市值 3767.38亿市值 2523.96亿市值 9.03亿成交额 3.13亿成交额 6.16亿成交额 25.42 17.23 45.39 -0.09(-0.35%) -0.10(-0.58%) +0.87(+1.95%) 消费电子 化学制药 工业富联 立讯精密 個瑞医药 3689.78亿市值 2202.50亿市值 3582.41亿市值 20.24亿成交额 6.16亿成交额 19.44亿成交额 18.58 30.39 ...